Xvivo Perfusion AB (publ) (XVIPF)

Market Cap	598.50M
Revenue (ttm)	86.54M
Net Income (ttm)	11.71M
Shares Out	n/a
EPS (ttm)	0.37
PE Ratio	51.10
Forward PE	59.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	173
Open	19.00
Previous Close	19.00
Day's Range	19.00 - 19.00
52-Week Range	18.20 - 51.16
Beta	1.89
RSI	26.20
Earnings Date	Oct 23, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 190
• Stock Exchange: OTCMKTS
• Ticker Symbol: XVIPF

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial numbers in SEK